🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rameswari Chilamakuri

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-4938-7368

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action”.

Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action

International Journal of Molecular Sciences(2022)10.3390/ijms231911455

N/A

0DataRank · unranked

14 citations

Rameswari Chilamakuri, Nishant S. Kulkarni, Nabeela Baig, Saurabh Agarwal, Vivek Gupta +1 more

Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer Agents

ChemMedChem(2024)10.1002/cmdc.202300715

N/A

0DataRank · unranked

3 citations

Pranav Gupta, Leonard Barasa, Rameswari Chilamakuri, Christopher K. Hlordzi, Nikita Acharekar +4 more

HJP 272, an endothelin receptor antagonist, and its role in cancer cell migration and invasion

Translational Oncology(2025)10.1016/j.tranon.2025.102492

N/A

0DataRank · unranked

0 citations

Rameswari Chilamakuri, Saurabh Agarwal, Aaron Muth, Sandra E. Reznik, Nabeela Baig